Mydecine Speaker Series: Part III-Drug Development

Posted By : User Ref No: WURUR74340 0
  • Image
  • TypeConference
  • Image
  • Location Online, Canada
  • Price
  • Date 18-02-2021
Mydecine Speaker Series: Part III-Drug Development, Online, Canada
Conference Title
Mydecine Speaker Series: Part III-Drug Development
Event Type
Conference
Conference Date
18-02-2021
Location
Online, Canada
Organization Name / Organize By
Microdose Psychedelic Insights
Organizing/Related Departments
Microdose Psychedelic Insights
Organization Type
Event Organizing Company
ConferenceCategory
Both (Technical & Non Technical)
ConferenceLevel
All (State/Province/Region, National & International)
Related Industries

Medical/Healthcare/Hospital

Location
Online, Canada

Mydecine Speaker Series III - Drug Development
Can Psychedelic Drug Design Improve Safety and Efficacy for Medicine?
Microdose invites you to join the Mydecine Speaker Series, dedicated to the exploration of the incredible findings around the current psychedelic research and what the path to mainstream acceptance looks like.

Featuring Dr. Denton Hoyer, Drug Discovery Consultant, Mydecine Innovations Group Inc.
Robert Roscow Chief Scientific Officer and Co-Founder Mydecine Innovations Group Inc.
Debra Borchardt Co-founder and CEO of the financial news website Green Market Report
Paul A. Frewen, Ph.D., C.Psych., Associate Professor

Others Details

Time: 13:30 - 15:00

Registration Fees
Available
Registration Fees Details
Free: CAD 0.0
Registration Ways
Website
Address/Venue
  Online 
Contact
Microdose Psychedelic Insights

[email protected]